Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07250815 · ClinicalTrials.gov registry record
A Study on Infections in Adults With Ulcerative Colitis/Crohn's Disease
A clinical trial, sponsored by Takeda.
- Not yet
- Registry status
- 23,900
- Enrollment target
NCT07250815 is a clinical trial that has not yet begun recruiting, run by Takeda. The registered enrollment target is 23,900 participants.
The verdict
NCT07250815 has not yet begun recruiting, sponsored by Takeda.
- NOT YET RECRUITING
- Registry status
- 23,900 participants
- Enrollment target
Study Summary
More older people (more than 65 years of age) around the world are getting Ulcerative Colitis (UC) or Crohn's Disease (CD). This is happening because people are living longer and because more people overall are developing UC or CD. Medicines that treat UC/CD, however, might make it easier for older adults to get infections. The main aim of this study is to learn if there is a difference in the number and type of infections in older people when treated with either ENTYVIO or other advance medicines (TNF-alpha inhibitors or ustekinumab) that reduce swelling and pain by blocking a chemical in the body (called TNF-alpha). The study will include people aged 65 years and older UC or CD who used either ENTYVIO with ustekinumab or a TNF-alpha inhibitor between 2016 and 2025. Data will be collected from existing Medicare databases.
Interventions
- OTHER No intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23,900 participants |
| Start Date | 2026-07-15 |
| Est. Completion | 2026-12-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07250815
The ClinicalTrials.gov registry entry for NCT07250815 describes a study currently listed as not yet recruiting, categorized as an unspecified phase. The registered enrollment target is 23,900 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Takeda, which has 408 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which No intervention is the first listed.
NCT07250815 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07250815 about?
NCT07250815 is a clinical study titled "A Study on Infections in Adults With Ulcerative Colitis/Crohn's Disease". More older people (more than 65 years of age) around the world are getting Ulcerative Colitis (UC) or Crohn's Disease (CD). This is happening because people are living longer and because more people overall are developing UC or CD. Medicines that treat UC/CD, however, might make it easier for older ...
What is the current status of trial NCT07250815?
This trial is currently not yet recruiting. The enrollment target is 23,900 participants. The study started on 2026-07-15. Estimated completion is 2026-12-15.
What interventions are being tested in trial NCT07250815?
The interventions under investigation include: No intervention (OTHER).
Who is sponsoring clinical trial NCT07250815?
This trial is sponsored by Takeda, which has 408 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.